Veradigm (MDRX) Status Update summary

Strategic and operational progress

• Signed over $30 million in new annual contract value in Q1 2025, a 25% year-over-year increase, with strong upsell to existing customers and new client wins, especially in specialty practices and value-based care solutions.

• Achieved recognition from KLAS and Black Book for payer analytics and payer insights, highlighting industry leadership and successful collaborations.

• Launched integrated Practice Fusion EHR, billing, and clearinghouse solution for small independent providers, and saw strong adoption of Veradigm Intelligent Payment Solution.

• Hosted a customer summit with 50% higher attendance, reinforcing market position and gathering positive feedback on solutions.

• Continued to expand in payer and life sciences, signing new Blues plans and multiple real-world evidence and data deals with pharma and healthcare organizations.

Financial performance and outlook

• Q1 2025 estimated GAAP revenue was $145–$147 million, up 1% year-over-year, with 78% recurring revenue.

• Provider segment revenue was flat, while payer and life science revenue grew 8% to $31–$32 million, driven by analytics and data exchange solutions.

• Cash and equivalents at March 31, 2025, were $272 million, down from $295 million at year-end 2024, with $208 million in convertible notes and $75 million drawn from a new $100 million credit facility.

• Outflows included $13 million for prior acquisitions, $6 million CapEx, and $4 million for operating activities, with $15 million in non-typical transaction and professional fees.

• Fiscal 2025 GAAP revenue expected to remain flat versus 2024, estimated at $583–$588 million, with a commitment to remain net cash positive and ongoing profitability improvement initiatives.

Capital structure and audit remediation

• Secured a $100 million senior secured loan from Francisco Partners, with $75 million drawn and $25 million available until December 2026, providing flexibility and no equity dilution.

• Convertible notes maturing in 2027 can be put for repayment as early as July 2025; company has sufficient cash to meet obligations, with potential $20 million additional repayment if all noteholders exercise repurchase option.

• Engaged BDO as new public accounting firm to complete 2023 and 2024 audits, aiming to regain SEC filing currency in 2026 and relist common stock.

• Material weaknesses in accounting are being addressed through new controls and ERP implementation, with operational reviews and cost structure improvements underway.

• Debt expected to rise to $283 million by June 30, 2025, including new borrowings.